Showing results (11-20 of 1,391) with videos related to
Sort By:
Pageof 140
JCO Precision Oncology|December 3, 2024
Evolution of Rapid Clonal Dynamics and Non-Cross-Resistance in Response to Alternating Targeted Therapy and Chemotherapy in BRAF-V600E-Mutant Colon CancerSrilatha Simhadri, Jillian N Carrick, Susan Murphy, et al.JCO Precision Oncology|December 6, 2024
Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete ResponseEric Michael Lander, Vasily N Aushev, Brandon M Huffman, et al.JCO Precision Oncology|December 5, 2024
Discovery of Gene Fusions in Driver-Negative Cancer Samples From the National Cancer Institute-Molecular Analysis for Therapy Choice Screening CohortStefan T Kaluziak, Elizabeth M Codd, Rashi Purohit, et al.JCO Precision Oncology|December 18, 2024
Longitudinal Testing of Circulating Tumor DNA in Patients With Metastatic Renal Cell CarcinomaArnab Basu, Cherry Au, Ajitha Kommalapati, et al.JCO Precision Oncology|December 12, 2024
Clinical Utility of Genomic Sequencing for Hereditary Cancer Syndromes: An Observational Cohort StudySalma Shickh, Chloe Mighton, Marc Clausen, et al.JCO Precision Oncology|November 15, 2024
Uptake of Aspirin Chemoprevention in Patients With Lynch SyndromeSachi Singhal, Emma D Riggs, Karen J Ruth, et al.JCO Precision Oncology|November 22, 2024
Genomic Alterations in DNA Mismatch Repair Genes Across Different Cancer TypesVijaykumar R Holla, Michael P Kahle, Sun-Hee Kim, et al.JCO Precision Oncology|October 9, 2025
Phase II Study of Vismodegib in Patients With SMO- or PTCH1-Mutated Tumors: Results From the National Cancer Institute Molecular Analysis for Therapy Choice Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Trial (EAY131) Subprotocol TAnne S Tsao, Zihe Song, Alan L Ho, et al.JCO Precision Oncology|October 16, 2025
Risks and Implications of Multiple Actionable Pathogenic Germline Variants Discovered by Panel-Based Cancer Predisposition TestingCatherine Neumann, Demitrios Dedousis, Michael J HallJCO Precision Oncology|October 11, 2025
Areas of Uncertainty in Pancreatic Cancer Surveillance: A Survey Across the International Pancreatic Cancer Early Detection (PRECEDE) ConsortiumAnjeli Manam, Jessica N Everett, Sigurdis Haraldsdottir, et al.Pageof 140